Parrado Raphael Hernando, Lemus Hernan Nicolas, Coral-Alvarado Paola Ximena, Quintana López Gerardo
Universidad de los Andes, Hospital Universitario Fundación Sante Fe de Bogotá, Bogotá, Colombia.
School of Medicine, Universidad de los Andes, Bogota, Colombia.
Int J Rheumatol. 2015;2015:762546. doi: 10.1155/2015/762546. Epub 2015 Nov 8.
Introduction. Gastric antral vascular ectasia (GAVE) is a rare entity with unique endoscopic appearance described as "watermelon stomach." It has been associated with systemic sclerosis but the pathophysiological changes leading to GAVE have not been explained and still remain uncertain. Methods. Databases Medline, Scopus, Embase, PubMed, and Cochrane were searched for relevant papers. The main search words were "Gastric antral vascular ectasia," "Watermelon Stomach," "GAVE," "Scleroderma," and "Systemic Sclerosis." Fifty-four papers were considered for this review. Results. GAVE is a rare entity in the spectrum of manifestations of systemic sclerosis with unknown pathogenesis. Most patients with systemic sclerosis and GAVE present with asymptomatic anemia, iron deficiency anemia, or heavy acute gastrointestinal bleeding. Symptomatic therapy and endoscopic ablation are the first-line of treatment. Surgical approach may be recommended for patients who do not respond to medical or endoscopic therapies. Conclusion. GAVE can be properly diagnosed and treated. Early diagnosis is key in the management of GAVE because it makes symptomatic therapies and endoscopic approaches feasible. A high index of suspicion is critical. Future studies and a critical review of the current findings about GAVE are needed to understand the role of this condition in systemic sclerosis.
引言。胃窦血管扩张症(GAVE)是一种罕见病症,具有独特的内镜表现,被描述为“西瓜胃”。它与系统性硬化症有关,但导致GAVE的病理生理变化尚未得到解释,仍然不确定。方法。检索了Medline、Scopus、Embase、PubMed和Cochrane数据库中的相关论文。主要检索词为“胃窦血管扩张症”、“西瓜胃”、“GAVE”、“硬皮病”和“系统性硬化症”。本综述纳入了54篇论文。结果。GAVE是系统性硬化症表现谱中的一种罕见病症,发病机制不明。大多数患有系统性硬化症和GAVE的患者表现为无症状性贫血、缺铁性贫血或严重的急性胃肠道出血。对症治疗和内镜下消融是一线治疗方法。对于对药物或内镜治疗无反应的患者,可能建议采用手术方法。结论。GAVE可以得到正确的诊断和治疗。早期诊断是GAVE管理的关键,因为它使对症治疗和内镜治疗方法可行。高度怀疑至关重要。需要对GAVE的当前研究结果进行进一步研究和批判性审查,以了解这种病症在系统性硬化症中的作用。